Search hospitals
>
California
>
Novato
Sutter Cancer Research Consortium
Claim this profile
Novato, California 94945
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Pancreatic Cancer
132 reported clinical trials
6 medical researchers
Summary
Sutter Cancer Research Consortium is a medical facility located in Novato, California. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer and other specialties. Sutter Cancer Research Consortium is involved with conducting 132 clinical trials across 287 conditions. There are 6 research doctors associated with this hospital, such as Ari Baron, MD, Deepti Behl, Kristie A. Bobolis, and Edmund W. Tai.
Area of expertise
Breast Cancer
Sutter Cancer Research Consortium has run 31 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Sutter Cancer Research Consortium has run 24 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Ari Baron, MD
Alta Bates Summit Medical Center-Herrick Campus
9 years of reported clinical research
Deepti Behl
California Pacific Medical Center-Pacific Campus
5 years of reported clinical research
Kristie A. Bobolis
Sutter Medical Center Sacramento
2 years of reported clinical research
Edmund W. Tai
Alta Bates Summit Medical Center-Herrick Campus
11 years of reported clinical research
Clinical Trials running at Sutter Cancer Research Consortium
Ovarian Cancer
Esophageal cancer
Breast Cancer
Kidney Cancer
Multiple Myeloma
Breast cancer
Esophageal Adenocarcinoma
Gastric cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Cancer
Olaparib +/- Bevacizumab
for Ovarian Cancer
This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving olaparib for one year with or without bevacizumab may be effective in treating patients with BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer, when compared to two years of olaparib.
Recruiting
2 awards
Phase 3
4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sutter Cancer Research Consortium?
Sutter Cancer Research Consortium is a medical facility located in Novato, California. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer and other specialties. Sutter Cancer Research Consortium is involved with conducting 132 clinical trials across 287 conditions. There are 6 research doctors associated with this hospital, such as Ari Baron, MD, Deepti Behl, Kristie A. Bobolis, and Edmund W. Tai.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.